[go: up one dir, main page]

CA2399776A1 - Acides nucleiques et polypeptides - Google Patents

Acides nucleiques et polypeptides Download PDF

Info

Publication number
CA2399776A1
CA2399776A1 CA002399776A CA2399776A CA2399776A1 CA 2399776 A1 CA2399776 A1 CA 2399776A1 CA 002399776 A CA002399776 A CA 002399776A CA 2399776 A CA2399776 A CA 2399776A CA 2399776 A1 CA2399776 A1 CA 2399776A1
Authority
CA
Canada
Prior art keywords
polypeptide
polynucleotide
protein
cells
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002399776A
Other languages
English (en)
Inventor
Y. Tom Tang
Chenghua Liu
Radoje T. Drmanac
Vinod Asundi
Ping Zhou
Chongjun Xu
Yicheng Cao
Yunquing Ma
Qing A. Zhao
Dunrui Wang
Jian-Rui Wang
Jie Zhang
Feiyan Ren
Rui-Hong Chen
Zhiwei Wang
Aidong J. Xue
Yonghong Yang
Tom Wehrman
Ryle Goodrich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nuvelo Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/728,422 external-priority patent/US20020128187A1/en
Application filed by Individual filed Critical Individual
Publication of CA2399776A1 publication Critical patent/CA2399776A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6432—Coagulation factor Xa (3.4.21.6)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21006—Coagulation factor Xa (3.4.21.6)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

L'invention concerne des acides nucléiques, des séquences polypeptidiques codées par ces acides nucléiques et leurs utilisations correspondantes.
CA002399776A 2000-02-03 2001-02-05 Acides nucleiques et polypeptides Abandoned CA2399776A1 (fr)

Applications Claiming Priority (17)

Application Number Priority Date Filing Date Title
US49691400A 2000-02-03 2000-02-03
US09/496,914 2000-02-03
US56087500A 2000-04-27 2000-04-27
US09/560,875 2000-04-27
US59807500A 2000-06-20 2000-06-20
US09/598,075 2000-06-20
US62032500A 2000-07-19 2000-07-19
US09/620,325 2000-07-19
US65493600A 2000-09-01 2000-09-01
US09/654,936 2000-09-01
US66356100A 2000-09-15 2000-09-15
US09/663,561 2000-09-15
US69332500A 2000-10-20 2000-10-20
US09/693,325 2000-10-20
US09/728,422 2000-11-30
US09/728,422 US20020128187A1 (en) 2000-02-03 2000-11-30 Novel nucleic acids and polypeptides
PCT/US2001/004098 WO2001057190A2 (fr) 2000-02-03 2001-02-05 Acides nucleiques et polypeptides

Publications (1)

Publication Number Publication Date
CA2399776A1 true CA2399776A1 (fr) 2001-08-09

Family

ID=27575454

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002399776A Abandoned CA2399776A1 (fr) 2000-02-03 2001-02-05 Acides nucleiques et polypeptides

Country Status (4)

Country Link
EP (1) EP1572987A4 (fr)
AU (1) AU2001234944A1 (fr)
CA (1) CA2399776A1 (fr)
WO (1) WO2001057190A2 (fr)

Families Citing this family (167)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001034627A1 (fr) * 1999-11-12 2001-05-17 Human Genome Sciences, Inc. 28 proteines humaines secretees
US20020137890A1 (en) 1997-03-31 2002-09-26 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US7057017B2 (en) 1997-04-16 2006-06-06 Millennium Pharmaceuticals, Inc. Human dickkopf-related protein and nucleic acid molecules and uses therefor
US20030068623A1 (en) 1997-06-16 2003-04-10 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US7446181B2 (en) 1998-01-15 2008-11-04 Millennium Pharmaceuticals, Inc. Antibodies that bind human Dickkopf-1 proteins
DE69941187D1 (de) 1998-06-01 2009-09-10 Agensys Inc Serpentintransmembranantigene exprimiert in menschlichem krebs und deren verwendungen
US20030149531A1 (en) 2000-12-06 2003-08-07 Hubert Rene S. Serpentine transmembrane antigens expressed in human cancers and uses thereof
US6833438B1 (en) 1999-06-01 2004-12-21 Agensys, Inc. Serpentine transmembrane antigens expressed in human cancers and uses thereof
US7264801B2 (en) 1998-08-11 2007-09-04 Genentech, Inc. EG-VEGF nucleic acids and polypeptides and method of use
US20020172678A1 (en) 2000-06-23 2002-11-21 Napoleone Ferrara EG-VEGF nucleic acids and polypeptides and methods of use
US20030003507A1 (en) 1999-06-02 2003-01-02 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
US6344541B1 (en) 1998-09-25 2002-02-05 Amgen Inc. DKR polypeptides
US6534485B1 (en) 1999-01-15 2003-03-18 Human Genome Sciences, Inc. Bone marrow-specific protein
US7034132B2 (en) 2001-06-04 2006-04-25 Anderson David W Therapeutic polypeptides, nucleic acids encoding same, and methods of use
EP1210418B1 (fr) * 1999-06-02 2010-08-18 Genentech, Inc. Polypeptides secretes et transmembranaires ainsi que les acides nucleiques codant pour ceux-ci
CN1377409A (zh) * 1999-08-19 2002-10-30 黑川清 Meg－1蛋白
US7790861B2 (en) * 1999-09-24 2010-09-07 Philadelphia Health And Education Corporation Prostate cancer-related compositions, methods, and kits based on DNA macroarray proteomics platforms
US20020042062A1 (en) 1999-09-24 2002-04-11 Mark Stearns Prostate cancer-related compositions, methods, and kits based on DNA macroarray proteomics platforms
EP1240350A4 (fr) 1999-12-23 2003-11-19 Millennium Pharm Inc Recepteur p2y12
WO2003048326A2 (fr) * 2001-12-03 2003-06-12 Nuvelo, Inc. Procedes et matieres associes a de nouveaux polypeptides et polynucleotides
AU781508B2 (en) 2000-02-11 2005-05-26 Glycozym Aps UDP-galactose: beta-D-galactose-R 4-alpha-D-galactosyltransferase, alpha4Gal-T1
JP4342069B2 (ja) * 2000-02-14 2009-10-14 生化学工業株式会社 α１，４−ガラクトース転移酵素およびそれをコードするＤＮＡ
AU6802801A (en) * 2000-03-01 2001-09-24 Genentech Inc Secreted and transmembrane polypeptides and nucleic acids encoding the same
WO2001070974A1 (fr) * 2000-03-24 2001-09-27 Takeda Chemical Industries, Ltd. Nouvelle proteine, son procede de production et d'utilisation
EP1268543A2 (fr) * 2000-04-05 2003-01-02 Kirin Beer Kabushiki Kaisha Methodes et materiaux relatifs a de nouveaux polypeptides et polynucleotides du type facteur de croissance des cellules-souches
AU2001268967A1 (en) * 2000-04-18 2001-10-30 Bayer Aktiengesellschaft Regulation of human epithin-like serine protease
AU2001257407A1 (en) * 2000-04-26 2001-11-07 Millennium Pharmaceuticals, Inc. 21657, a human short-chain dehydrogenase and uses thereof
US7510845B2 (en) 2000-05-04 2009-03-31 California Institute Of Technology Assay employing G protein-coupled receptor expressed in dorsal root ganglia
US20030092035A1 (en) 2000-05-04 2003-05-15 Anderson David J. Pain signaling molecules
US7117033B2 (en) 2000-05-08 2006-10-03 Brainsgate, Ltd. Stimulation for acute conditions
WO2001085935A2 (fr) * 2000-05-09 2001-11-15 Bayer Aktiengesellschaft Recepteur couple a une proteine g du type du gene 6 de differenciation endotheliale
WO2001092494A2 (fr) * 2000-05-26 2001-12-06 Millennium Pharmaceuticals, Inc. Nouvelle lipase humaine 50250 et utilisations
WO2001096375A2 (fr) * 2000-06-16 2001-12-20 Millennium Pharmaceuticals, Inc. La 33358, nouveau membre de la famille humaine des ankyrines et ses utilisations
CA2414015A1 (fr) * 2000-06-21 2001-12-27 Incyte Genomics, Inc. Recepteurs
WO2002000861A2 (fr) * 2000-06-26 2002-01-03 Millennium Pharmaceuticals, Inc. 46619, une nouvelle synthase beta-cetoacyle et utilisations de cette derniere
WO2002002599A2 (fr) * 2000-06-30 2002-01-10 Ingenium Pharmaceuticals Ag Recepteur couple aux proteines g humaines igpcr17, et son utilisation
WO2002006312A2 (fr) * 2000-07-13 2002-01-24 Novartis Ag Gene associe a une maladie
WO2002008392A2 (fr) * 2000-07-25 2002-01-31 Bayer Aktiengesellschaft Regulation de la serine protease humaine semblable a matriptase
EP1315431A1 (fr) * 2000-08-02 2003-06-04 Millennium Pharmaceuticals, Inc. Membre de la famille du facteur de liberation du gtp humain (15368) et ses utilisations
CA2416732C (fr) 2000-08-02 2016-02-09 Brad St. Croix Profils d'expression de cellules endotheliales
DE60121346T8 (de) * 2000-08-04 2007-12-13 Ludwig Institute For Cancer Research Suppressor-Gen
EP1688496A3 (fr) * 2000-08-14 2006-08-16 Actimis Pharmaceuticals, Inc., Régulation du récepteur couple aux protéines g du type récepteur p2y1
ES2258553T3 (es) * 2000-08-14 2006-09-01 Actimis Pharmaceuticals, Inc. Regulacion del receptor acoplado a la proteina g humana del tipo p2y1.
US20020156259A1 (en) * 2000-08-15 2002-10-24 Conklin Darrell C. Human adenosine deaminase
US6706513B2 (en) 2000-08-21 2004-03-16 Bristol-Myers Squibb Company Adenosine deaminase homolog
US20030166300A1 (en) * 2000-08-30 2003-09-04 Tang Y. Tom Growth-related inflammatory and immune response protein
AU2001285908A1 (en) * 2000-08-30 2002-03-13 Bayer Aktiengesellschaft Regulation of human aminotransferase-like enzyme
WO2002022777A2 (fr) * 2000-09-15 2002-03-21 Institut National De La Sante Et De La Recherche Medicale (Inserm) Genes cellulaires impliques dans l'oncogenese, les produits de ces genes et leurs applications diagnostiques et therapeutiques
US7754435B2 (en) * 2000-09-21 2010-07-13 Philadelphia Health And Education Corporation Prostate cancer-related compositions, methods, and kits based on DNA macroarray proteomics platforms
AU2002211502A1 (en) * 2000-10-04 2002-04-15 Curagen Corporation Novel proteins and nucleic acids encoding same and antibodies directed against these proteins
AU2002220613A1 (en) * 2000-10-11 2002-04-22 Bayer Aktiengesellschaft Regulation of human cyclophilin-type peptidyl-prolyl cis-trans isomerase
WO2002095032A2 (fr) 2000-10-19 2002-11-28 Millenium Pharmaceuticals, Inc. 69087, 12821, et 15418, procedes et compositions de proteines humaines et leurs utilisations
EP1332157A2 (fr) 2000-11-03 2003-08-06 The Regents of the University of California Polypeptides de prokineticine, et methodes et compositions associees
AU2001297575A1 (en) * 2000-11-08 2002-10-08 Millennium Pharmaceuticals, Inc. 38650, 28472, 5495, 65507, 81588 and 14354 methods and compositions of human proteins and uses thereof
WO2002038743A2 (fr) * 2000-11-09 2002-05-16 Glaxo Group Limited Enzyme
AU3769902A (en) * 2000-11-09 2002-05-21 Univ Virginia Human testis specific serine/threonine kinase
US7312086B2 (en) 2000-12-07 2007-12-25 Bristol-Myers Squibb Company Methods of diagnosing colon adenocarcinoma using the human g-protein coupled receptor hgprbmy23
JP2005508600A (ja) * 2000-12-21 2005-04-07 インサイト・ゲノミックス・インコーポレイテッド 核酸関連タンパク質
US7892730B2 (en) * 2000-12-22 2011-02-22 Sagres Discovery, Inc. Compositions and methods for cancer
US20030148920A1 (en) * 2000-12-27 2003-08-07 Steven Rosen Sulfatases and methods of use thereof
WO2002053719A2 (fr) * 2001-01-04 2002-07-11 Incyte Genomics, Inc. Proteines associees au cytosquelette
EP1360295A2 (fr) * 2001-01-05 2003-11-12 Incyte Genomics, Inc. Molecules pour la detection de maladies et traitement
US6319679B1 (en) * 2001-01-26 2001-11-20 Board Of Regents, The University Of Texas System PAS kinase
US20020115136A1 (en) * 2001-02-07 2002-08-22 Gennady Merkulov Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
WO2002064777A2 (fr) * 2001-02-14 2002-08-22 Axaron Bioscience Ag Proteines 7b6 et 11b4 et sequences d'adn codant pour celles-ci
WO2002074913A2 (fr) * 2001-03-16 2002-09-26 Incyte Genomics, Inc. Proteines associees a des acides nucleiques
US20030044813A1 (en) * 2001-03-30 2003-03-06 Old Lloyd J. Cancer-testis antigens
US20020146795A1 (en) * 2001-04-02 2002-10-10 Shiaoping Zhu Isolated human Ras-like proteins, nucleic acid molecules encoding these human Ras-like proteins, and uses thereof
US7033790B2 (en) 2001-04-03 2006-04-25 Curagen Corporation Proteins and nucleic acids encoding same
US7927597B2 (en) * 2001-04-10 2011-04-19 Agensys, Inc. Methods to inhibit cell growth
WO2002083921A2 (fr) 2001-04-10 2002-10-24 Agensys, Inc. Acides nucleiques et proteines correspondantes utiles pour la detection et le traitement de divers cancers
US6962811B2 (en) 2001-05-09 2005-11-08 Millennium Pharmaceuticals, Inc. 14715, a human fringe family member nucleic acids and uses therefor
JP4231778B2 (ja) 2001-05-29 2009-03-04 株式会社ヒューマンセルシステムズ 精巣型カルニチントランスポーターとその遺伝子
CA2449289A1 (fr) 2001-06-05 2002-12-12 Exelixis, Inc. Gfat en tant que modificateurs de la voie p53 et leur procede d'utilisation
KR100788092B1 (ko) * 2001-06-20 2007-12-21 제넨테크, 인크. 종양의 진단 및 치료를 위한 방법 및 이를 위한 조성물
AU2002319261A1 (en) * 2001-06-25 2003-01-08 Bayer Aktiengesellschaft Regulation of human serine/threonine protein kinase nek3
AU2002336446B2 (en) 2001-09-06 2008-03-06 Agensys, Inc. Nucleic acid and corresponding protein entitled STEAP-1 useful in treatment and detection of cancer
US7494646B2 (en) 2001-09-06 2009-02-24 Agensys, Inc. Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
EP1526382B1 (fr) * 2001-09-24 2007-01-03 Grünenthal GmbH Procédé de criblage pour différentes indications à l'aide de la proteine DNPI
US7265214B2 (en) 2001-10-19 2007-09-04 Rigel Pharmaceuticals, Inc. Germinal center kinase proteins, compositions and methods of use
WO2003038040A2 (fr) * 2001-10-29 2003-05-08 Millennium Pharmaceuticals, Inc. 32235, membre de la famille de l'aminotransferase humaine et ses utilisations
AU2002363227A1 (en) * 2001-10-31 2003-05-12 Millennium Pharmaceuticals, Inc. Methods for the treatment and diagnosis of tumorigenic and angiogenic disorders using 32616
US20030143231A1 (en) * 2001-10-31 2003-07-31 Millennium Pharmaceuticals, Inc. Methods and compositions for the treatment and diagnosis of pain disorders using 57749
DE60220621T2 (de) 2001-11-09 2008-03-06 Proteologics, Inc. Posh Nukleinsäure, Polypeptide und darauf bezogene Verfahren
US20050004056A1 (en) * 2001-12-04 2005-01-06 Martin Meise Ptp10d, tec protein tyrosine kinase and edtp homologous proteins involved in the regulation of energy homeostasis
WO2003054153A2 (fr) * 2001-12-12 2003-07-03 University Of Cincinnati Polypeptides de l'apyrase et acides nucleiques codant pour ces polypeptides
US7858297B2 (en) 2001-12-18 2010-12-28 Centre National De La Recherche Scientifique Cnrs Chemokine-binding protein and methods of use
JP2005527191A (ja) * 2001-12-18 2005-09-15 アンドキューブ ソシエタ パー アクシオン シンプリフィー 新規の細胞死関連タンパク質ならびにアポトーシス制御におけるｔｈａｐ１およびｐａｒ４の経路
AU2003244347A1 (en) * 2002-02-04 2003-09-02 Takeda Chemical Industries, Ltd. Angiogenesis inhibitors
GB0205112D0 (en) * 2002-03-05 2002-04-17 Pantherix Ltd Enzyme
EP1495806B1 (fr) 2002-03-11 2013-12-04 Japan Science and Technology Agency Catalyseur chiral de zirconium
DE10212397A1 (de) 2002-03-20 2003-10-16 Universitaetsklinikum Freiburg Repressor der Skelettmuskeldifferenzierung, dafür kodierende Nucleinsäure und dessen Verwendung in Diagnostik und Therapie
US20050065082A1 (en) * 2002-03-29 2005-03-24 Hirofumi Doi C-jun phosphorylation inhibitors
US20050202431A1 (en) * 2002-04-01 2005-09-15 National Institute Of Advanced Industrial Science Application of kiaa0172 gene to treatment and diagnosis of diseases and drug discovery
US7622443B2 (en) 2002-04-26 2009-11-24 California Institute Of Technology Method for inhibiting pro-angiogenic activities of endothelial cells selectively at a site of neoangiogenesis in a mammal by administration of the extracellular domain of D1-1 polypeptides
AU2003234274A1 (en) 2002-04-26 2003-11-10 California Institute Of Technology D1-1 nucleic acids, polypeptides and related methods
DE10222845A1 (de) * 2002-05-23 2003-12-04 Dresden Arzneimittel Klonierung, Expression und Charakterisierung der Gesamtsequenz von Phosphodiesterase 8B
EP2275573A1 (fr) * 2002-06-28 2011-01-19 Imclone LLC Anticorps pour le diagnostic et le traitement de l'adénocarcinome gastrique
US7135556B2 (en) 2002-07-19 2006-11-14 Schering Corporation NPC1L1 (NPC3) and methods of use thereof
CA2493007A1 (fr) * 2002-07-19 2004-01-29 Cellzome Ag Complexes proteiques de la proteine activatrice de la transcription de tip60
JP2004290170A (ja) * 2002-08-02 2004-10-21 Takeda Chem Ind Ltd 疾患関連遺伝子の用途
TW200413725A (en) * 2002-09-30 2004-08-01 Oncotherapy Science Inc Method for diagnosing non-small cell lung cancers
US7056685B1 (en) 2002-11-05 2006-06-06 Amgen Inc. Receptor ligands and methods of modulating receptors
US7561919B2 (en) 2002-11-14 2009-07-14 Brainsgate Ltd. SPG stimulation via the greater palatine canal
US20080213166A1 (en) * 2002-11-20 2008-09-04 Biogen Idec Inc. Novel Gene Targets and Ligands that Bind Thereto for Treatment and Diagnosis of Colon Carcinomas
AU2003300680A1 (en) * 2002-12-10 2004-07-09 Centre National De La Recherche Scientifique Cnrs Thap proteins as nuclear receptors for chemokines and roles in transcriptional regulation, cell proliferation and cell differentiation
JP4140951B2 (ja) * 2002-12-18 2008-08-27 独立行政法人科学技術振興機構 転写制御因子ｚｈｘ３
WO2004061108A1 (fr) 2002-12-29 2004-07-22 Toudai Tlo, Ltd. Recepteur de l'adiponectine et gene codant pour ce recepteur
US7259002B2 (en) 2003-01-21 2007-08-21 Bristol-Myers Squibb Company Polynucleotide encoding a novel acyl coenzyme A, monoacylglycerol acyltransferase-3 (MGAT3), and uses thereof
KR100937614B1 (ko) 2003-02-03 2010-01-20 도쿠리쓰교세이호징 가가쿠 기주쓰 신코 기코 Ｏｔｘ2 유전자를 사용한 망막 시각세포의 재생과 신생
AU2004293369A1 (en) * 2003-03-03 2005-06-09 Genentech, Inc. Compositions and methods for the treatment of systemic lupus erythematosis
CA2522994C (fr) * 2003-04-30 2012-09-25 Agensys, Inc. Acides nucleiques et proteines correspondantes appelees 109p1d4 utiles dans le traitement et la detection du cancer
WO2004104218A1 (fr) * 2003-05-23 2004-12-02 Bayer Healthcare Ag Agents diagnostiques et therapeutiques destines a des maladies associees a x-prolyl aminopeptidase 1 (xpnpep1)
WO2005023855A2 (fr) * 2003-09-10 2005-03-17 Friedrich-Alexander-Uni- Versitatet Erlangen- Nuernberg Gene et proteine k203
US7534562B2 (en) * 2003-09-30 2009-05-19 Daiichi Pharmaceutical Co., Ltd. Tetrahydrofolate synthetase gene
WO2005059504A2 (fr) * 2003-12-12 2005-06-30 Bayer Healthcare Ag Diagnostics et therapeutique destines au traitement de maladies associees au recepteur couple aux proteines g gpr34 (gpr34)
JP4590417B2 (ja) 2004-01-16 2010-12-01 メルク・シャープ・エンド・ドーム・コーポレイション Ｎｐｃ１ｌ１（ｎｐｃ３）およびこのリガンドの同定方法
JP2007521835A (ja) * 2004-02-10 2007-08-09 トラスティーズ・オブ・ダートマウス・カレッジ ニコチンアミドリボシドキナーゼ組成物およびそれらの使用方法
US8010189B2 (en) 2004-02-20 2011-08-30 Brainsgate Ltd. SPG stimulation for treating complications of subarachnoid hemorrhage
US9233245B2 (en) 2004-02-20 2016-01-12 Brainsgate Ltd. SPG stimulation
US8055347B2 (en) 2005-08-19 2011-11-08 Brainsgate Ltd. Stimulation for treating brain events and other conditions
EP1786833A4 (fr) * 2004-03-19 2009-02-25 Univ Yale Detection, isolement et utilisations de la renalase (monoamine oxydase de type c)
CN1950397B (zh) * 2004-03-30 2012-05-16 Ns基因公司 生长因子NsG33的治疗用途
US20050222040A1 (en) * 2004-04-05 2005-10-06 Blm Group, Inc. Vertebrate peptide modulators of lipid metabolism
NZ550816A (en) 2004-04-22 2009-12-24 Agensys Inc Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
MX2007001221A (es) 2004-08-04 2007-03-23 Amgen Inc Anticuerpos para proteina dickkopf-1 (dkk-1).
WO2006069592A2 (fr) * 2004-12-31 2006-07-06 Vereniging Voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek En Patientenzorg Methode permettant de diagnostiquer et/ou de predire la toxemie preeclamptique et/ou des troubles associes
FI20050011A7 (fi) * 2005-01-05 2006-07-06 Oy Jurilab Ltd Menetelmä ja testipakkaus tyypin 2 diabetes mellituksen riskin havaitsemiseksi
WO2006074914A2 (fr) * 2005-01-13 2006-07-20 Novartis Forschungsstiftung, Zweigniederlassung Friedrich Miescher Institute For Biomedical Research Helicase d'arn humaine et ses utilisations therapeutiques
US7521195B1 (en) 2005-07-21 2009-04-21 Celera Corporation Lung disease targets and uses thereof
US7858084B2 (en) 2005-11-21 2010-12-28 Yale University Methods of treatment with renalase (monoamine oxidase C)
US9206242B2 (en) * 2005-11-22 2015-12-08 National University Corporation Nagoya University Application of actin-binding protein to disease associated with cell motility
US7910698B2 (en) 2006-02-24 2011-03-22 Schering Corporation NPC1L1 orthologues
MX2009003938A (es) 2006-10-27 2009-04-24 Genentech Inc Anticuerpos e inmunoconjugados y sus usos.
WO2008136541A1 (fr) * 2007-05-02 2008-11-13 Snu R&Db Foundation Inhibiteur de l'angiogenèse comprenant de la météorine en tant que principe actif
SI2173379T1 (sl) 2007-07-02 2015-12-31 Oncomed Pharmaceuticals, Inc. Sestavki in postopki za zdravljenje in diagnosticiranje raka
EP2170374A2 (fr) * 2007-07-03 2010-04-07 Andreas Reichert Procédé de traitement de maladies liées à un dysfonctionnement mitochondrial
WO2009014450A1 (fr) * 2007-07-24 2009-01-29 Sanare As Nouveaux peptides
EP2227487A1 (fr) 2007-12-28 2010-09-15 Novo Nordisk A/S Purification cellulaire à médiation par ddr1 de cellules endocrines pancréatiques par leurs progénitrices
WO2010009732A1 (fr) 2008-07-24 2010-01-28 Nsgene A/S Utilisation thérapeutique d'un facteur de croissance, metrnl
ES2742251T3 (es) 2009-03-16 2020-02-13 Pangu Biopharma Ltd Composiciones y procedimientos que comprenden variantes de splicing de histidil-tarn sintetasa que tienen actividades biológicas no canónicas
AR075989A1 (es) 2009-04-10 2011-05-11 Lilly Co Eli Anticuerpo dkk -1 (dickkopf-1) humano disenado por ingenieria
US8815779B2 (en) 2009-09-16 2014-08-26 SwitchGear Genomics, Inc. Transcription biomarkers of biological responses and methods
TWI507524B (zh) 2009-11-30 2015-11-11 Genentech Inc 診斷及治療腫瘤之組合物及方法
CN102821784B (zh) 2009-12-11 2016-09-21 Atyr医药公司 用于调节炎症的氨酰tRNA合成酶
JP6008843B2 (ja) 2010-05-04 2016-10-19 エータイアー ファーマ， インコーポレイテッド グルタミル−プロリルｔＲＮＡ合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見
CN103108649B (zh) 2010-07-12 2016-10-12 Atyr医药公司 与组氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物
ES2584068T3 (es) 2010-10-01 2016-09-23 Nsgene A/S Uso de meteorina para el tratamiento de alodinia, hiperalgesia, dolor espontáneo y dolor fantasma
MX349198B (es) 2011-07-15 2017-07-18 Oncomed Pharmaceuticals Inc * Agentes que se unen a las proteinas de r-espondinas (rspo) y usos de los mismos.
WO2013034157A1 (fr) 2011-09-05 2013-03-14 Nsgene A/S Traitement de l'allodynie, de l'hyperalgie, de la douleur spontanée et de la douleur illusionnelle
DK2814514T3 (en) 2012-02-16 2017-12-18 Atyr Pharma Inc Histidyl tRNA synthetases for the treatment of autoimmune and inflammatory diseases
WO2014012007A2 (fr) 2012-07-13 2014-01-16 Oncomed Pharmaceuticals, Inc. Agents de liaison des protéines rspo3 et leurs utilisations
EP2742935A1 (fr) * 2012-12-14 2014-06-18 Tissue Med Biosciences Forschungs- und Entwicklungsgesellschaft mbH SERF2 pour traiter l'atrophie ou augmenter la croissance cellulaire
ES2847383T3 (es) 2013-03-15 2021-08-03 Atyr Pharma Inc Conjugados de Fc-histidil-ARNt sintetasa
US9675796B2 (en) 2013-11-10 2017-06-13 Brainsgate Ltd. Implant and delivery system for neural stimulator
EP3193935A4 (fr) 2014-09-16 2018-03-21 Oncomed Pharmaceuticals, Inc. Traitement de maladies fibrotiques
EP3093043B1 (fr) 2015-05-13 2018-11-14 Brainsgate Ltd. Implant et système de distribution pour stimulateur neural
EP3548039B1 (fr) 2016-12-04 2023-07-19 Alavi Khorassani Moghadam, Marcel Victor Ribavirine pour sa l'utilisation dans le traitement d'une maladie mitochondriale
US10905766B2 (en) * 2017-03-23 2021-02-02 Oregon State University Therapeutic compositions and methods for treatment of muscle wasting diseases
AU2018247767B2 (en) 2017-04-03 2025-01-30 F. Hoffmann-La Roche Ag Antibodies binding to STEAP-1
EP3612215B1 (fr) 2017-04-20 2024-08-28 aTyr Pharma, Inc. Compositions pour le traitement d'inflammation pulmonaire
AU2019347666B2 (en) 2018-09-28 2025-10-02 President And Fellows Of Harvard College Cellular reprogramming to reverse aging and promote organ and tissue regeneration
US12274733B2 (en) 2018-09-28 2025-04-15 President And Fellows Of Harvard College Cellular reprogramming to reverse aging and promote organ and tissue regeneration
CN110910960B (zh) * 2019-11-30 2022-07-08 浙江天科高新技术发展有限公司 一种鲍曼不动杆菌分子血清型快速分析方法
AU2021394748A1 (en) * 2020-12-08 2023-06-08 Imagine Pharma Llc Compositions and methods for treating wounds
US12252518B2 (en) 2023-01-06 2025-03-18 Life Biosciences, Inc. Methods of treating non-arteritic anterior ischemic optic neuropathy
WO2025068459A2 (fr) * 2023-09-29 2025-04-03 Universität Zu Köln Outil et procédé de désagrégation de protéines contenant un étirement polyq

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5474796A (en) * 1991-09-04 1995-12-12 Protogene Laboratories, Inc. Method and apparatus for conducting an array of chemical reactions on a support surface
AU7172198A (en) * 1997-04-29 1998-11-24 Incyte Pharmaceuticals, Inc. Human c-type lectin
GB9711148D0 (en) * 1997-05-31 1997-07-23 Peptide Therapeutics Ltd Human MAFA

Also Published As

Publication number Publication date
AU2001234944A8 (en) 2006-12-21
AU2001234944A1 (en) 2001-08-14
WO2001057190A3 (fr) 2006-11-16
EP1572987A4 (fr) 2005-11-30
EP1572987A2 (fr) 2005-09-14
WO2001057190A2 (fr) 2001-08-09

Similar Documents

Publication Publication Date Title
US6743619B1 (en) Nucleic acids and polypeptides
CA2399776A1 (fr) Acides nucleiques et polypeptides
CA2402563A1 (fr) Nouveaux acides nucleiques et polypeptides
EP1325120A2 (fr) Acides nucleiques et polypeptides
CA2440257A1 (fr) Nouveaux acides nucleiques et polypeptides
WO2002022660A2 (fr) Noveaux acides nucleiques et polypeptides
EP1504099A2 (fr) Nouveaux acides nucleiques et polypeptides
WO2001066689A2 (fr) Nouveaux acides nucleiques et polypeptides
WO2001053455A2 (fr) Nouveaux acides nucleiques et polypeptides associes
EP1661986A1 (fr) Acides nucléiques et protéines codées par ces derniers qui sont membre de la famille génique des kallikréines
EP1556490A2 (fr) Nouveaux acides nucleiques et polypeptides
WO2003029271A2 (fr) Nouveaux acides nucleiques et polypeptides
EP1368475A1 (fr) Nouveaux acides nucleiques et nouveaux polypeptides
CA2401505A1 (fr) Nouveaux acides nucleiques et polypeptides
WO2002018424A9 (fr) Nouveaux acides nucleiques et polypeptides
CA2456955A1 (fr) Nouveaux acides nucleiques et polypeptides secretes
WO2005049806A2 (fr) Nouveaux acides nucleiques et polypeptides
EP1341803A2 (fr) Nouveaux acides nucleiques et polypeptides
US20050221342A1 (en) Nucleic acids and polypeptides
WO2002077180A2 (fr) Nouveaux acides nucleiques et nouveaux polypeptides
CA2409164A1 (fr) Nouveaux acides nucleiques et polypeptides
WO2001075093A1 (fr) Nouveaux acides nucleiques et polypeptides
CA2406121A1 (fr) Nouveaux acides nucleiques et nouveaux polypeptides
EP1591448A2 (fr) Nouveaux acides nucléiques et polypeptides
CA2453344A1 (fr) Nouveaux acides nucleiques et nouveaux polypeptides

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued